HOUSTON, July 18, 2023 /PRNewswire/ — As previously announced by the Company on July 17, 2023, the Board of Directors of the Company has authorized the Company to proceed with the implementation of a holding company reorganization, which will involve the incorporation of a new holding…
Month: July 2023
SAN FRANCISCO, July 18, 2023 /PRNewswire/ — Elizée, the Italian, women-led, sustainable luxury footwear brand featuring an innovative, patent-pending comfort insole, proudly introduces its Summer launch, showcasing two ultra-wearable new silhouettes, including enchanting new bridal…
BLUE BELL, Pa., July 18, 2023 /PRNewswire/ — Unisys (NYSE: UIS) announces the dates for its second-quarter 2023 financial results and conference call and its participation in an upcoming investor conference. Second-Quarter 2023 Financial Results Unisys will release its second-quarter…
DUBLIN, July 18, 2023 /PRNewswire/ — The “Calcium Channel Blocker Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. The global calcium channel blocker market is poised for significant growth, projected to reach $14.66 billion in 2023 with a compound…
DALLAS, July 18, 2023 /PRNewswire/ — EnLink Midstream, LLC (NYSE: ENLC) (EnLink) today announced a quarterly distribution for the second quarter of 2023 and announced it will host a webcast and conference call on Wednesday, August 2, at 8 a.m. Central time to discuss its second quarter…
The inflammatory myositis market is anticipated to surge owing to improvements in diagnosis over the globe and thus the surge in treatment options. In addition, the expected launch of emerging therapies by leading companies such as CSL Behring, Immunoforge Co. Ltd., Argenx, Janssen,…
CALGARY, AB, July 18, 2023 /PRNewswire/ – Canadian Pacific Kansas City (TSX: CP) (NYSE: CP) (CPKC) today announced the 2816 Empress steam locomotive will travel from Canada, through the U.S. and into Mexico departing Calgary, Alta. on April 14, 2024, the one-year anniversary of CPKC’s…
MELBOURNE, Australia, July 18, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase I study of the Company’s investigational targeted radiation therapy, TLX250, in combination with a Merck KGaA,…
MELBOURNE, Australia, July 18, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase I study of the Company’s investigational targeted radiation therapy, TLX250, in combination with a Merck KGaA,…
This Sponsorship Supports Increasing Access to High-Quality Veterinary Care and Training Programs in Economically-Disadvantaged Communities Worldwide LOS ANGELES, July 18, 2023 /PRNewswire/ — Ultimate Pet Nutrition®, the innovative, award-winning, pet nutrition brand that provides…